Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment83

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment35

Views

Views
June 20250
July 202518
August 20250
September 20255
October 20253
November 20257
December 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Brazil11
United Kingdom5
Ecuador1
Egypt1
Kenya1
Panama1
Paraguay1
Senegal1
Venezuela1
 

Top cities views

Views
Ashburn3
Alexandria1
Baltimore1
Caraguatatuba1
Ciudad Ojeda1
Dakar1
Dallas1
Duque de Caxias1
Greenwich1
Lajeado1